Stress-Induced Hyperglycemia (SIH) Stress-Induced Hyperglycemia (SIH) David Ray Velez, MD Table of Contents DefinitionPathophysiologyEffects/ComplicationsTreatment Definition Definition: Abnormal Rise in Blood Sugar Caused by Illness, Physical Stress, or Psychological StressCausesSurgeryCritical IllnessTraumaBurnsAny Other Cause of Significant Stress Pathophysiology PathophysiologyPrimary Factors:Increased GluconeogenesisHepatic Insulin ResistanceRelease of Excessive Counterregulatory HormonesRelative Overall State of Insulin ResistanceImpaired Glucose Transporter (GLUT)-4 Receptor TranslocationImpaired Skeletal Muscle Uptake of GlucoseCounterregulatory HormonesGlucagonCortisol – Increased Gluconeogenesis and Protein CatabolismGrowth Hormone – Inhibits Insulin ReceptorsCatecholamines – Promote Hepatic Glucose ProductionCytokines (IL-1, IL-6, TNF-Alpha) – Promote Hepatic Glucose Production Effects/Complications Effects of Hyperglycemia in Critical IllnessIncreased Oxidative InjuryIncreased Proinflammatory ResponseIncreased HypercoagulabilityImmunosuppressionAbnormal Vascular ReactivityPotential Osmotic DiuresisIncreased Morbidity and MortalityHigh Glucose Variability is Also Associated with Increased MortalityComplicationsMyocardial Infarction (MI)StrokeConfusionInfections/SepsisImpaired Wound HealingRenal FailureIncreased MortalityIncreased Risk for Developing Type 2 Diabetes After Recovery Treatment Correct Any Underlying CausesPrimary Treatment: InsulinGenerally Start with a Sliding-Scale RegimenMay Require Insulin InfusionGeneral Glucose TargetGoal Blood Glucose ≤ 140-180 mg/dLLevels > 180 mg/dL Increase the Risk for Postoperative Complications, SSI, LOS, and MortalityEffect is More Pronounced in Non-Diabetic Patients than in Diabetic PatientsOverly Strict Glucose Control Increases the Risk of Hypoglycemia without Improved Outcomes*NICE SUGAR Trial – Found Increased Mortality with Intensive Insulin Therapy (Goals 81-108 mg/dL)